Innovative Therapies and Clinical Studies for Screenable Disorders (R21)

The summary for the Innovative Therapies and Clinical Studies for Screenable Disorders (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Innovative Therapies and Clinical Studies for Screenable Disorders (R21)
	CFDA Number:	93.17393.847
	CFDA Description:	Research Related to Deafness and Communication Disorders 93.847 Diabetes, Endocrinology and Metabolism Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-06-342
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Apr 10, 2006
	Creation Date:	Oct 05, 2007
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Dec 05, 2008
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	93.865 -- Child Health and Human Development Extramural Research

Applicants Eligible for this Grant: Small businesses Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Public housing authorities/Indian housing authorities Independent school districts County governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations
Grant Description: The National Institute of Child Health and Human Development (NICHD), the National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite applications for research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future. In this Funding Opportunity Announcement (FOA), a high priority condition is a condition for which the development of an efficacious therapy would make the condition amenable to newborn screening. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. -This FOA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-06-341 and PAR-06-060, that utilize the Small Research Grant (R03) and the traditional Research Project Grant (R01) award mechanisms, respectively. - Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. - Eligible Organizations: For-profit and non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government; domestic or foreign institution/organizations; faith-based or community-based organizations; units of State Tribal government; and units of Local Tribal government. - Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-06-342.html http://grants.nih.gov/grants/guide/pa-files/PAR-06-342.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster